Modelling the Reverse ElectroDialysis process with seawater and concentrated brines

Technologies for the exploitation of renewable energies have been dramatically increasing in number, complexity and type of source adopted. Among the others, the use of saline gradient power is one of the latest emerging possibilities, related to the use of the osmotic/chemical potential energy of concentrated saline solutions. Nowadays, the fate of this renewable energy source is intrinsically linked to the development of the pressure retarded osmosis and reverse electrodialysis technologies. In the latter, the different concentrations of two saline solutions is used as a driving force for the direct production of electricity within a stack very similar to the conventional electrodialysis ones. In the present work, carried out in the EU-FP7 funded REAPower project, a multi-scale mathematical model for the Salinity Gradient Power Reverse Electrodialysis (SGP-RE) process with seawater and concentrated brines has been developed. The model is based on mass balance and constitutive equations collected from relevant scientific literature for the simulation of the process under extreme conditions of solutions concentration. A multi-scale structure allows the simulation of the single cell pair and the entire SGP-RE stack. The first can be seen as the elementary repeating unit constituted by cationic and anionic membrane and the relevant two channels where dilute and concentrate streams flow. The reverse electro-dialysis stack is constituted by a number of cell pairs, the electrode compartments and the feed streams distribution system. The model has been implemented using gPROMS , a powerful dynamic modelling process simulator. Experimental information, collected from the FUJIFILM laboratories in Tilburg (the Netherlands), has been used to perform the tuning of model formulation and eventually to validate model predictions under different operating conditions. Finally, the model has been used to simulate different possible scenarios and perform a preliminary analysis of the influence of some process operating conditions on the final stack performance

CFD modelling of profiled-membrane channels for reverse electrodialysis

Abstract: Reverse electrodialysis (RE) is a promising technology for electric power generation from controlled mixing of two differently concentrated salt solutions, where ion-exchange membranes are adopted for the generation of ionic currents within the system. Channel geometry strongly influences fluid flow and thus crucial phenomena such as pressure drop and concentration polarization. Profiled membranes are an alternative to the more commonly adopted net spacers and offer a number of advantages: avoiding the use of non-conductive and relatively expensive materials, reducing hydraulic losses and increasing the active membrane area. In this work, Computational Fluid Dynamic simulations were performed to predict the fluid flow and mass transfer behaviour in channels with profiled membranes for RE applications. In particular, channels equipped with pillars were simulated. The influence of channel geometry on fluid flow and concentration polarization was assessed by means of a parametric analysis for different profile geometries. The unit cell approach along with periodic boundary conditions was adopted to simulate fully developed boundary conditions. Transport equations, valid also for concentrated solutions, were obtained from the rigorous Stefan–Maxwell equation along with the assumptions of binary electrolyte and local electroneutrality. Simulation results show that, in the geometries investigated here, the pumping power consumption is much lower than in a conventional net spacer and very close to that of the empty channel, while calm zones are generated by the profiles, which may accentuate polarization phenomena

A novel Reverse Electrodialysis application to generate power from low-grade heat

A novel idea for the conversion of low-temperature heat into electricity is based on the generation of electricity from salinity gradients using a Reverse Electrodialysis (RED) device in a closed-loop system. In this concept a limited amount of artificial saline solutions can be used as the working fluids in a closed-loop. The solutions exiting from the RED unit are then regenerated, in order to restore the original salinity gradient, by means of a separation step, which uses low-temperature heat (40-100°C) as its energy source. A theoretical analysis of potentials of this technology is illustrated in the present work

Association of ABCB1, 5-HT3B receptor and CYP2D6 genetic polymorphisms with ondansetron and metoclopramide antiemetic response in Indonesian cancer patients treated with highly emetogenic chemotherapy.

Our study shows that in Indonesian cancer patients treated with highly cytostatic emetogenic, carriership of the CTG haplotype of the ABCB1 gene is related to an increased risk of delayed chemotherapy-induced nausea and vomiting

Effect of beta-adrenergic stimulation on whole-body and abdominal subcutaneous adipose tissue lipolysis in lean and obese men

AIMS/HYPOTHESIS: Obesity is characterised by increased triacylglycerol storage in adipose tissue. There is in vitro evidence for a blunted beta-adrenergically mediated lipolytic response in abdominal subcutaneous adipose tissue (SAT) of obese individuals and evidence for this at the whole-body level in vivo. We hypothesised that the beta-adrenergically mediated effect on lipolysis in abdominal SAT is also impaired in vivo in obese humans. METHODS: We investigated whole-body and abdominal SAT glycerol metabolism in vivo during 3 h and 6 h [2H5]glycerol infusions. Arterio-venous concentration differences were measured in 13 lean and ten obese men after an overnight fast and during intravenous infusion of the non-selective beta-adrenergic agonist isoprenaline [20 ng (kg fat free mass)(-1) min(-1)]. RESULTS: Lean and obese participants showed comparable fasting glycerol uptake by SAT (9.7+/-3.4 vs 9.3+/-2.5% of total release, p=0.92). Furthermore, obese participants showed an increased whole-body beta-adrenergically mediated lipolytic response versus lean participants. However, their fasting lipolysis was blunted [glycerol rate of appearance: 7.3+/-0.6 vs 13.1+/-0.9 micromol (kg fat mass)(-1) min(-1), p<0.01], as was the beta-adrenergically mediated lipolytic response per unit SAT [Delta total glycerol release: 140+/-71 vs 394+/-112 nmol (100 g tissue)(-1) min(-1), p<0.05] compared with lean participants. Net triacylglycerol flux tended to increase in obese compared with lean participants during beta-adrenergic stimulation [Delta net triacylglycerol flux: 75+/-32 vs 16+/-11 nmol (100 g tissue)(-1) min(-1), p=0.06]. CONCLUSIONS/INTERPRETATION: We demonstrated in vivo that beta-adrenergically mediated lipolytic response is impaired systematically and in abdominal SAT of obese versus lean men. This may be important in the development or maintenance of increased triacylglycerol stores and obesity

Direct-Acting Antiviral Treatment for Hepatitis C Genotypes Uncommon in High-Income Countries:A Dutch Nationwide Cohort Study

Background. The majority of hepatitis C virus (HCV) infections are found in low- and middle-income countries, which harbor many region-specific HCV subtypes. Nevertheless, direct-acting antiviral (DAA) trials have almost exclusively been conducted in high-income countries, where mainly epidemically spread HCV subtypes are present. Recently, several studies have demonstrated suboptimal DAA efficacy for certain nonepidemic subtypes, which could hamper global HCV elimination. Therefore, we aimed to evaluate DAA efficacy in patients treated for a nonepidemic HCV genotype infection in the Netherlands. Methods. We performed a nationwide retrospective study including patients treated with interferon-free DAAs for an HCV genotype other than 1a/1b/2a/2b/3a/4a/4d. The genotype was determined by NS5B region phylogenetic analysis. The primary end point was SVR-12. If stored samples were available, NS5A and NS5B sequences were obtained for resistance-associated substitutions (RAS) evaluation. Results. We included 160 patients, mainly infected with nonepidemic genotype 2 (41%) and 4 (31%) subtypes. Most patients were from Africa (45%) or South America (24%); 51 (32%) were cirrhotic. SVR-12 was achieved in 92% (140/152) of patients with available SVR-12 data. Only 73% (8/11) genotype 3-infected patients achieved SVR-12, the majority being genotype 3b patients with 63% (5/8) SVR. Regardless of SVR, all genotype 3b patients had 30K and 31M RAS. Conclusions. (T)he DAA efficacy we observed in most nonepidemic genotypes in the Netherlands seems reassuring. However, the low SVR-12 rate in subtype 3b infections is alarming, especially as it is common in several HCV-endemic countries. Alongside earlier results, our results indicate that a remaining challenge for global HCV elimination is confirming and monitoring DAA efficacy in nonepidemic genotypes